Zimmer Biomet (Germany) Performance
| ZIM Stock | EUR 103.15 0.10 0.1% |
Zimmer Biomet has a performance score of 1 on a scale of 0 to 100. The firm maintains a market beta of 0.23, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Zimmer Biomet's returns are expected to increase less than the market. However, during the bear market, the loss of holding Zimmer Biomet is expected to be smaller as well. Zimmer Biomet Holdings right now maintains a risk of 1.77%. Please check out Zimmer Biomet Holdings sortino ratio, potential upside, skewness, as well as the relationship between the maximum drawdown and semi variance , to decide if Zimmer Biomet Holdings will be following its historical returns.
Risk-Adjusted Performance
1 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Zimmer Biomet Holdings are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, Zimmer Biomet is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 478.5 M |
Zimmer |
Zimmer Biomet Relative Risk vs. Return Landscape
If you would invest 10,214 in Zimmer Biomet Holdings on August 25, 2024 and sell it today you would earn a total of 101.00 from holding Zimmer Biomet Holdings or generate 0.99% return on investment over 90 days. Zimmer Biomet Holdings is currently producing 0.0307% returns and takes up 1.7707% volatility of returns over 90 trading days. Put another way, 15% of traded stocks are less volatile than Zimmer, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Zimmer Biomet Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Zimmer Biomet's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Zimmer Biomet Holdings, and traders can use it to determine the average amount a Zimmer Biomet's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0173
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ZIM |
Estimated Market Risk
| 1.77 actual daily | 15 85% of assets are more volatile |
Expected Return
| 0.03 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Zimmer Biomet is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Zimmer Biomet by adding it to a well-diversified portfolio.
Zimmer Biomet Fundamentals Growth
Zimmer Stock prices reflect investors' perceptions of the future prospects and financial health of Zimmer Biomet, and Zimmer Biomet fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Zimmer Stock performance.
| Return On Equity | 0.0236 | |||
| Return On Asset | 0.0371 | |||
| Profit Margin | 0.03 % | |||
| Operating Margin | 0.19 % | |||
| Current Valuation | 29.79 B | |||
| Shares Outstanding | 210.06 M | |||
| Price To Earning | 10.60 X | |||
| Price To Book | 2.15 X | |||
| Price To Sales | 3.27 X | |||
| Revenue | 6.94 B | |||
| EBITDA | 1.49 B | |||
| Cash And Equivalents | 403.1 M | |||
| Cash Per Share | 1.97 X | |||
| Total Debt | 5.32 B | |||
| Debt To Equity | 74.70 % | |||
| Book Value Per Share | 57.51 X | |||
| Cash Flow From Operations | 1.28 B | |||
| Earnings Per Share | 1.30 X | |||
| Total Asset | 21.07 B | |||
About Zimmer Biomet Performance
By analyzing Zimmer Biomet's fundamental ratios, stakeholders can gain valuable insights into Zimmer Biomet's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Zimmer Biomet has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Zimmer Biomet has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana. ZIMMER BIOMET operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 19000 people.Things to note about Zimmer Biomet Holdings performance evaluation
Checking the ongoing alerts about Zimmer Biomet for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Zimmer Biomet Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Zimmer Biomet has accumulated €5.32 Billion in debt which can lead to volatile earnings | |
| Over 91.0% of the company outstanding shares are owned by institutional investors |
- Analyzing Zimmer Biomet's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Zimmer Biomet's stock is overvalued or undervalued compared to its peers.
- Examining Zimmer Biomet's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Zimmer Biomet's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Zimmer Biomet's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Zimmer Biomet's stock. These opinions can provide insight into Zimmer Biomet's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Zimmer Stock analysis
When running Zimmer Biomet's price analysis, check to measure Zimmer Biomet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zimmer Biomet is operating at the current time. Most of Zimmer Biomet's value examination focuses on studying past and present price action to predict the probability of Zimmer Biomet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zimmer Biomet's price. Additionally, you may evaluate how the addition of Zimmer Biomet to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |